A general in vitro assay to study enzymatic activities of the ubiquitin system
File(s)Zuo_etal_revised_final_resubmit3.pdf (3.08 MB)
Accepted version
Author(s)
Type
Journal Article
Abstract
The ubiquitin (Ub) system regulates a wide range of cellular signaling pathways. Several hundred E1, E2 and E3 enzymes are together responsible for protein ubiquitination, thereby controlling cellular activities. Due to the numerous enzymes and processes involved, studies on ubiquitination activities have been challenging. We here report a novel FRET-based assay to study the in vitro kinetics of ubiquitination. FRET is established between binding of fluorophore-labeled Ub to eGFP-tagged ZnUBP, a domain that exclusively binds unconjugated Ub. We name this assay the Free Ub Sensor System (FUSS). Using Uba1, UbcH5 and CHIP as model E1, E2 and E3 enzymes, respectively, we demonstrate that ubiquitination results in decreasing FRET efficiency, from which reaction rates can be determined. Further treatment with USP21, a deubiquitinase, leads to increased FRET efficiency, confirming the reversibility of the assay. We subsequently use this assay to show that increasing the concentration of CHIP or UbcH5 but not Uba1 enhances ubiquitination rates, and develop a novel machine learning approach to model ubiquitination. The overall ubiquitination activity is also increased upon incubation with tau, a substrate of CHIP. Our data together demonstrate the versatile applications of a novel ubiquitination assay that does not require labeling of E1, E2, E3 or substrates, and is thus likely compatible with any E1-E2-E3 combinations.
Date Issued
2020-02-25
Date Acceptance
2020-01-17
Citation
Biochemistry, 2020, 59 (7), pp.851-861
ISSN
0006-2960
Publisher
American Chemical Society
Start Page
851
End Page
861
Journal / Book Title
Biochemistry
Volume
59
Issue
7
Copyright Statement
© 2020 American Chemical Society. This document is the Accepted Manuscript version of a Published Work that appeared in final form in Biochemistry, after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acs.biochem.9b00602.
Sponsor
Wellcome Trust
UK Dementia Research Institute
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/31951392
Subjects
Biochemistry & Molecular Biology
0304 Medicinal and Biomolecular Chemistry
0601 Biochemistry and Cell Biology
1101 Medical Biochemistry and Metabolomics
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2020-01-17